Saira Ramasastry, Director at Vir Biotechnology, Inc. (VIR), sold 1,687 shares at $23.82 ($40K) on 2022-05-24, disclosed to the SEC on 2022-05-25.
Scheduled sale ($40k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MIRM | SELL | 2026-04-16 | $194K | — | Filing → |
| MIRM | SELL | 2026-03-17 | $182K | — | Filing → |
| MIRM | SELL | 2026-02-17 | $204K | — | Filing → |